InsidersTradesSigma
Total declarations
Companies
▲ Purchases (7 ops.)
▼ Sales (1 ops.)
Insider track record
OtherDisclosed buys
7
Disclosed sells
1
Not enough buy signals with a settled T+90 horizon to measure a track record yet.
Signal history
Explore the detailed record of transactions filed by Poplar Point Capital Partners Lp. Director active across 2 companies, notably Gyrodyne, LLC. In total, 8 filings have been recorded. Breakdown: 7 buys · 1 sell. Total volume traded: €394k. Activity tracked since 27 August 2021. The latest transaction was filed on 18 March 2025 (Acquisition). Regulator: SEC (Form 4). The full history is accessible without signup.
Companies and markets linked to Poplar Point Capital Partners Lp
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
Declarations8 total
14,000 shares@ US$0.6313.2% of flowCommon Stock, par value $0.01 per shareSEC:0001398344-25-007144:0
Canonical exit: 16 Jun 2025 (T+90)
2,597 shares@ US$0.6352.6% of flowCommon Stock, par value $0.01 per shareSEC:0001398344-25-007136:0
Canonical exit: 4 May 2025 (T+90)
31,703 shares@ US$0.6934.1% of flowCommon Stock, par value $0.01 per shareSEC:0001398344-25-007133:0
Canonical exit: 27 Apr 2025 (T+90)
917 shares@ US$0.580.8% of flowCommon Stock, par value $0.01 per shareSEC:0001398344-25-007148:0
Canonical exit: 1 Jul 2025 (T+90)
13,292 shares@ US$0.60912.3% of flowCommon Stock, par value $0.01 per shareSEC:0001398344-25-007146:0
Canonical exit: 24 Jun 2025 (T+90)
25,033 shares@ US$0.619924.2% of flowCommon Stock, par value $0.01 per shareSEC:0001398344-25-007139:0
Canonical exit: 26 May 2025 (T+90)
14,645 shares@ US$0.5812.8% of flowCommon Stock, par value $0.01 per shareSEC:0001398344-25-007141:0
Canonical exit: 8 Jun 2025 (T+90)
30,000 shares@ US$13.04100.0% of flowCommon StockSEC:0001104659-21-111223:0
8 of 8 declarations
About Poplar Point Capital Partners Lp
POPLAR POINT CAPITAL PARTNERS LP is a declarant with 8 filings in total. In the recent filings available, they cover the period from 2021-08-30 to 2025-04-15, with buys of EUR 61231 and sells of EUR 332755. The companies mentioned are NovaBay Pharmaceuticals, Inc. and Gyrodyne, LLC.
